MAXHEALTH - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.4
| Stock Code | MAXHEALTH | Market Cap | 97,634 Cr. | Current Price | 1,004 ₹ | High / Low | 1,314 ₹ |
| Stock P/E | 141 | Book Value | 87.4 ₹ | Dividend Yield | 0.15 % | ROCE | 12.5 % |
| ROE | 9.45 % | Face Value | 10.0 ₹ | DMA 50 | 1,043 ₹ | DMA 200 | 1,102 ₹ |
| Chg in FII Hold | -1.25 % | Chg in DII Hold | 1.17 % | PAT Qtr | 160 Cr. | PAT Prev Qtr | 166 Cr. |
| RSI | 47.9 | MACD | -24.2 | Volume | 46,92,119 | Avg Vol 1Wk | 42,89,714 |
| Low price | 934 ₹ | High price | 1,314 ₹ | PEG Ratio | 4.46 | Debt to equity | 0.08 |
| 52w Index | 18.4 % | Qtr Profit Var | -30.6 % | EPS | 6.60 ₹ | Industry PE | 44.0 |
📊 Analysis: Max Healthcare is trading at 1,004 ₹, below both its 50 DMA (1,043 ₹) and 200 DMA (1,102 ₹), indicating short-term and medium-term weakness. RSI at 47.9 suggests neutral-to-weak momentum, while MACD (-24.2) reflects bearish sentiment. Intraday volume (46.9 lakh) is slightly above the weekly average (42.9 lakh), showing healthy participation. Fundamentals are mixed—EPS at 6.60 ₹ and steady revenue base support the stock, but high P/E (141 vs industry 44) and declining quarterly profit (-30.6%) limit valuation comfort.
💰 Optimal Buy Price (Intraday): 995–1,005 ₹ (near support zone).
📈 Profit-Taking Levels: 1,020 ₹ (first resistance), 1,040 ₹ (secondary resistance).
⚠️ Stop-Loss / Loss Protection: 985 ₹ (below intraday support).
⏱️ If Already Holding: Exit if price fails to sustain above 1,020 ₹ with volume confirmation or if RSI dips below 46 intraday. Hold for extended gains only if momentum sustains above 1,040 ₹ with strong volume recovery.
Positive
- 📈 EPS at 6.60 ₹ supports earnings base.
- 📊 DII holdings increased (+1.17%).
- 📉 Debt-to-equity at 0.08, low leverage.
- 📈 Strong intraday volume compared to weekly average.
Limitation
- ⚠️ Current price below both 50 DMA and 200 DMA.
- 📉 MACD (-24.2) indicates bearish momentum.
- 📊 High P/E (141) vs industry average (44.0).
- 📉 PEG ratio at 4.46 suggests expensive growth valuation.
Company Negative News
- 📉 Quarterly PAT declined (166 Cr. → 160 Cr.).
- ⚠️ Profit variation (-30.6%) shows weakening momentum.
- 📉 FII holdings decreased (-1.25%).
Company Positive News
- 📈 DII accumulation (+1.17%) supports sentiment.
- 📊 EPS strength and low debt provide financial stability.
Industry
- 🏥 Healthcare sector PE at 44.0, Max trades at a steep premium (141).
- 📈 Sector supported by long-term demand for healthcare services and hospital expansion.
Conclusion
⚖️ Max Healthcare is a moderate intraday candidate. Buy near 995–1,005 ₹ with stop-loss at 985 ₹. Profit booking can be considered at 1,020–1,040 ₹. Momentum indicators suggest caution, as MACD remains bearish despite strong volume. Traders should rely on volume confirmation before holding beyond 1,040 ₹.
Would you like me to also prepare a peer benchmarking overlay comparing Max Healthcare with Apollo Hospitals, Fortis Healthcare, and Narayana Hrudayalaya to highlight relative intraday strength in the healthcare sector?